Michelle Kramer - Concepedia

Author

Michelle Kramer

Johnson & Johnson (United States)ORCID

Also Known As

M KRAMER, M Kramer, M. Kramer, M. Krämer, Michelle Kramer, Michelle L. Kramer, Mitroff, Stephen

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)Janssen (United States)Janssen (Belgium)

About

Michelle Kramer is an author at Johnson & Johnson (United States) specializing in medicine, pharmacotherapy, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.2K
2	Social Sciences	3	3	500
3	Natural Sciences	1	1	17
4	Biochemistry	1	1	17
5	Geriatrics	1	1	90

Michelle Kramer

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial☆ John M. Kane, F. Cañas, Michelle Kramer, Schizophrenia Research PsychiatryPsychotic DisorderPsychotropic Medication6-Week Placebo-controlled Trial☆Psychopharmacology	2006	281
Rapid Antimanic Effect of Risperidone Monotherapy: A 3-Week Multicenter, Double-Blind, Placebo-Controlled Trial Robert M. A. Hirschfeld, Paul E. Keck, Michelle Kramer, American Journal of Psychiatry	2004	258
Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study Michael Davidson, Robin Emsley, Michelle Kramer, Schizophrenia Research Early ResponsePsychotropic MedicationPatient SafetyClinical TrialsRehabilitation	2007	237
Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study Stephen R. Marder, Michelle Kramer, Lisa Ford, Biological Psychiatry Drug SafetyMedicineClinical TrialsPlacebo-controlled StudyPharmacotherapy	2007	219
Paliperidone Extended-Release Tablets for Prevention of Symptom Recurrence in Patients With Schizophrenia Michelle Kramer, George M. Simpson, Valentinas Mačiulis, Journal of Clinical Psychopharmacology Symptom RecurrencePsychiatryPaliperidone Extended-releasePsychotropic MedicationPsychotic Disorder	2007	208
Risperidone in the treatment of acute mania Sumant Khanna, Eduard Vieta, Benjamin Lyons, The British Journal of Psychiatry	2005	188
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol Smulevich Ab, Sumant Khanna, Mariëlle Eerdekens, European Neuropsychopharmacology 9-Week Double-blind TrialPsychiatryMedicinePsychotropic MedicationDepression	2004	178
Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study Michelle Kramer, Robert E. Litman, David Hough, The International Journal of Neuropsychopharmacology	2009	162
Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets in the Treatment of Acute Schizophrenia Herbert Y. Meltzer, William V. Bobo, Isaac F. Nuahmah, The Journal of Clinical Psychiatry	2008	158
Efficacy of olanzapine in social anxiety disorder: a pilot study Stewart D. Barnett, Michelle Kramer, Charles D. Casat, Journal of Psychopharmacology	2002	124

Page 1